Nxstage Medical, Inc. (NASDAQ:NXTM) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 5.24%.
Nxstage Medical, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.08 in the quarter versus EPS of $-0.09 in the year-earlier quarter.
Revenue: Rose 8.17% to $61.6 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Nxstage Medical, Inc. reported adjusted EPS loss of $0.08 per share. By that measure, the company met the mean analyst estimate of $-0.08. It beat the average revenue estimate of $61.14 million.
Quoting Management: “Our first quarter performance represents a good start to the year,” stated Jeffrey H. Burbank, Founder and Chief Executive Officer of NxStage. “In addition to meeting our near-term financial objectives, we’re on track with strong and systematic execution against initiatives that are focused on accelerating growth over the long term. Our recent regulatory successes which include approval for a number of significant product innovations, including CE mark for nocturnal home dialysis and both CE mark and FDA clearance for our new high flow capabilities with our System One, reinforce our confidence in our ability to reduce barriers to home adoption and drive demand for our therapy.”
Key Stats (on next page)…
Revenue decreased 5.26% from $65.02 million in the previous quarter. EPS decreased to $-0.08 in the quarter versus EPS of $-0.04 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.03 to a loss $0.07. For the current year, the average estimate has moved down from a loss of $0.12 to a loss of $0.24 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)